Robyn Karnauskas
Stock Analyst at Truist Securities
(1.92)
# 2,898
Out of 4,826 analysts
182
Total ratings
41.67%
Success rate
-1.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robyn Karnauskas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Hold | $333 → $298 | $279.80 | +6.50% | 12 | Jan 8, 2025 | |
| BMY Bristol-Myers Squibb Company | Maintains: Buy | $62 → $65 | $50.06 | +29.84% | 2 | Jan 8, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $130 → $110 | $82.84 | +32.79% | 11 | Jan 8, 2025 | |
| GILD Gilead Sciences | Maintains: Hold | $82 → $83 | $102.81 | -19.27% | 18 | Aug 15, 2024 | |
| ABBV AbbVie | Reiterates: Buy | $195 → $210 | $196.07 | +7.10% | 8 | Jul 26, 2024 | |
| BMEA Biomea Fusion | Downgrades: Hold | n/a | $2.00 | - | 3 | Jun 11, 2024 | |
| BIIB Biogen | Maintains: Buy | $340 | $121.80 | +179.15% | 17 | May 16, 2024 | |
| CRIS Curis | Maintains: Buy | $26 | $2.45 | +961.22% | 2 | May 15, 2024 | |
| CHRS Coherus BioSciences | Maintains: Buy | $8 → $7 | $1.02 | +586.27% | 13 | May 13, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,135 | $603.58 | +88.04% | 16 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $1.68 | +497.01% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $2.87 | +213.59% | 4 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $74 | $15.91 | +365.12% | 2 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $11.58 | +98.70% | 5 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $15.23 | +215.17% | 5 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $8.93 | +460.22% | 8 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $850 | $821.46 | +3.47% | 4 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $456 → $508 | $500.19 | +1.56% | 13 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $36 | $23.88 | +50.75% | 5 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $25 | $40.78 | -38.70% | 1 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.69 | - | 6 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $140 | $62.06 | +125.59% | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.10 | +13,536.36% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $7 | $1.17 | +498.29% | 3 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $15.89 | +246.13% | 1 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.06 | - | 4 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $2.19 | +1,224.20% | 1 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $320 | $14.05 | +2,177.58% | 2 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $4.93 | +204.26% | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $3.41 | +633.14% | 1 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $85 | $0.44 | +19,315.26% | 1 | Oct 8, 2020 |
Amgen
Jan 8, 2025
Maintains: Hold
Price Target: $333 → $298
Current: $279.80
Upside: +6.50%
Bristol-Myers Squibb Company
Jan 8, 2025
Maintains: Buy
Price Target: $62 → $65
Current: $50.06
Upside: +29.84%
Merck & Co.
Jan 8, 2025
Downgrades: Hold
Price Target: $130 → $110
Current: $82.84
Upside: +32.79%
Gilead Sciences
Aug 15, 2024
Maintains: Hold
Price Target: $82 → $83
Current: $102.81
Upside: -19.27%
AbbVie
Jul 26, 2024
Reiterates: Buy
Price Target: $195 → $210
Current: $196.07
Upside: +7.10%
Biomea Fusion
Jun 11, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.00
Upside: -
Biogen
May 16, 2024
Maintains: Buy
Price Target: $340
Current: $121.80
Upside: +179.15%
Curis
May 15, 2024
Maintains: Buy
Price Target: $26
Current: $2.45
Upside: +961.22%
Coherus BioSciences
May 13, 2024
Maintains: Buy
Price Target: $8 → $7
Current: $1.02
Upside: +586.27%
Regeneron Pharmaceuticals
Apr 3, 2024
Maintains: Buy
Price Target: $1,135
Current: $603.58
Upside: +88.04%
Mar 26, 2024
Maintains: Buy
Price Target: $10
Current: $1.68
Upside: +497.01%
Mar 26, 2024
Maintains: Buy
Price Target: $9
Current: $2.87
Upside: +213.59%
Mar 25, 2024
Reiterates: Buy
Price Target: $74
Current: $15.91
Upside: +365.12%
Mar 25, 2024
Reiterates: Buy
Price Target: $23
Current: $11.58
Upside: +98.70%
Mar 25, 2024
Reiterates: Buy
Price Target: $48
Current: $15.23
Upside: +215.17%
Mar 25, 2024
Reiterates: Buy
Price Target: $50
Current: $8.93
Upside: +460.22%
Mar 22, 2024
Reiterates: Buy
Price Target: $850
Current: $821.46
Upside: +3.47%
Jan 31, 2024
Maintains: Buy
Price Target: $456 → $508
Current: $500.19
Upside: +1.56%
Dec 14, 2023
Maintains: Buy
Price Target: $42 → $36
Current: $23.88
Upside: +50.75%
Oct 6, 2023
Downgrades: Hold
Price Target: $25
Current: $40.78
Upside: -38.70%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.69
Upside: -
Sep 25, 2023
Reiterates: Buy
Price Target: $140
Current: $62.06
Upside: +125.59%
Sep 6, 2023
Reiterates: Buy
Price Target: $150
Current: $1.10
Upside: +13,536.36%
Aug 16, 2023
Reiterates: Hold
Price Target: $7
Current: $1.17
Upside: +498.29%
May 11, 2023
Maintains: Buy
Price Target: $65 → $55
Current: $15.89
Upside: +246.13%
Dec 6, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.06
Upside: -
Nov 16, 2022
Initiates: Buy
Price Target: $29
Current: $2.19
Upside: +1,224.20%
Aug 23, 2022
Maintains: Buy
Price Target: $500 → $320
Current: $14.05
Upside: +2,177.58%
Aug 9, 2022
Maintains: Buy
Price Target: $10 → $15
Current: $4.93
Upside: +204.26%
Nov 11, 2020
Initiates: Buy
Price Target: $25
Current: $3.41
Upside: +633.14%
Oct 8, 2020
Initiates: Buy
Price Target: $85
Current: $0.44
Upside: +19,315.26%